## 



## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

|||Note|2022||2021||
|---|---|---|---|---|---|---|
||||f||f||
|Fixed Assets:|||||||
|Investments|||||||
|Geneml Fund|||5,041,345||4,847,908||
|Endowment<br>Funds|—Expendable||82,086||78,517||
|Endowment<br>funds|- Permanent||46,680||44,743||
|Restricted Funds|||52,991||50,269||
|||||5,223,102||5.021,437|
|Current Assets:|||||||
|Cash at bank:|||||||
|Current account|||74,067||1,815||
|Deposit accounts|||98,695||237,916||
||||172,762||239,731||
|Current Liabilities|||||||
|Amounts<br>falling due within one year|||69,205||61,202||
|Net Current Assets||||103,557||178,529|
|Net Assets||||5,326,659||5 199966|
|Funds:|||||||
|Unrestricted<br>Funds||4||5.102,251||4,985,507|
|Restricted Funds||5||75,273||72,651|
|Endowment<br>Funds - Expendable||6||96,668||91,918|
|Endowment<br>Funds -Permanent||7||52,467||49,890|
|||||5.326659||5 199966|
|Approved<br>etru|on 27June 2022 and|signed on their behalf by:|||||
|...... ................................,.......Mr.JEChurch (Chairman)|||||||
|/i~|......Mr. AP Q Michaelis (Trustee)||||||





## 

## 

||||||Endowment|Endowment|Total|Total|
|---|---|---|---|---|---|---|---|---|
||||I/nrestricted|Restricted|Espendable|Permanent|||
||||Funds|Funds|Funds|Funds|2022|2021|
|lacome aad Eadowments||from|||||||
|Stocks|and shares||133+50|1,875|2,458|1,334|138,917|140,669|
|Deposit|interest||12||||13|228|
|Doaatious|||||||60|5|
||||133,322|1,875|2,459|1,334|138,990|140,902|
|Expenditure|ou||||||||
|Charitable|activities|(Note 10)|(142,875)|(1,000)|||(143,875)|(120,896)|
|Generating|funds||||||||
|Investment|management|charges|2,132||||2,132|(I5308)|
|Net gains/(losses)<br>oa investments|||124,165|1,747|2,291|1343|129,446|1,189,403|
|Net Income/(espeaditure)|||116,744|2,622|4,750|2,577|126,693|1,194,101|
|Other gainsdosses|||||||||
|Net Movement|in Funds||116,744|2,622|4,750|2877|126,693|1,194,101|
|Fund balances brought||forward|4,985,507|72,651|91,918|49,890|5,199,966|4,005,865|
|Fund balances carried||farward|5,102351|75273|96,668|52,467|5,326,659|5,199,966|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

|Quoted Investments|||Trust|Pool||Trust|Trust|
|---|---|---|---|---|---|---|---|
||||Apportioned|Between||Pool|Pool|
|||||Endowment||Total|Total|
|||Unrestricted|Restricted|Expendable|Permanent|||
|||Funds|Funds|Funds|Funds|2022|2021|
|||||f.|||f|
|Market Value at31March 2021||4,847,908|50,269|78,517|44,743|5,021,437|3,793,736|
|Add: Additions atcost||5,017,209|70,613|92,582|50,214|5,230,618|472,033|
|Less: Disposals||(4,947,937)|(69,638)|(91,304)|(49,520)|(5,158,399)|(433,735)|
|Gain/(Loss) on revaluation||124,165|1,747|2,291|1,243|129,446|1,189,403|
|Market Value at31 March 2022||5041 345|52 991|82 086|46.680|5 223 102|5021 437|
|The Sarasin Endowments|Fund Class A Income units are||invested as follows.|||||
|Equities||||||3,634,483|3,783,569|
|Fixed interest||||||365,060|445,885|
|Other||||||1,223,559|791,983|
|||||||5,223,102|5021437|
|Historic Cost at31March 2022||||||5,230,618|3 189,419|





## 

## 

||||||2022||2021|
|---|---|---|---|---|---|---|---|
|3.Current Liabilities||||||||
|Grants and|awards||||66,130||57,690|
|Professional|fees||||1,425||1,380|
|Investment|management|charges|||||2.132|
|Salary ofsecretary|||||1,650|||
||||||69,205||61,202|
|4.Unrestricted|li'unde|||||||
|Balance at|1April 2021 - Capital||||4,838,084||3,706,689|
|||-income|||147,423||131,475|
||||||4,985,507||3,838,164|
|Net surplus|for the year||||116,744||1,147,343|
|Balaace at|31March|2022|||||4,985.507|
|5.Restricted Funds||||||||
||||||Gain oa|||
||||I April 2021|Income|nevslnsaon|Ktpeaditnre|31 Msr 2022|
|Theatres (Biomet) Fund|||2,353||||2,353|
|John Spivey Prize|||70,298|1,875|1,747|(1,000)|72,920|
||||72 651|1,875|1,747|I 000|75273|



## 

|||Bslsnce st I April 2021|Bslsnce st I April 2021||Gaia os|Krpenditnre|Balance|
|---|---|---|---|---|---|---|---|
||FUIIB|Capital|||Rerstnatma||31Msr 2022|
|John Goodfellow<br>Prize||25,714|8,869|931|867||36,381|
|David Fuller|Memorial|13,558|1,682|403|375||16,018|
|Girdlestone|Society-R BDuthie Fund|32,185|9,910|1,125|1,049||44,269|
|||71.457|20,461|2,459|2391||96.668|





## 

||Balance|Gain on|Kxpenditme|Balance|
|---|---|---|---|---|
|1|April 2e21|Revaluation||31Mar 2102|
|||||f|
||40,635|1,243||41.878|
||40,635|1 243||41 878|
||Balaoce|Income|Kxpeaditnre|Balance|
|1|April 2021|||31Star 2022|
||9,255|1,334||10,589|
||9455|1334||10589|
|||2022||2021|
|||||S|
|||52,467||49.890|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|9.Analysis ofCharitable<br>Expenditure|9.Analysis ofCharitable<br>Expenditure|9.Analysis ofCharitable<br>Expenditure|||2022|2021|
|---|---|---|---|---|---|---|
|Grants and awards (note 10)|||||132,760|110,575|
|Other charitable<br>expenditure<br>(note|11)||||10,115|9,321|
||||||142,875|119896|
|10.Grants and Awards|||||||
||||||2022|2021|
||||||8||
|Lord Nuffield<br>Scholarship<br>in orthopaedic|||surgery||32,875|32,550|
|Girdlestone<br>Memorial<br>scholarship<br>in||orthopaedic||surgery|32,875|32,550|
|Research grants|||||32,350|19,425|
|Total orthopaedic<br>scholarships|||||98,100|84,525|
|Kenwright<br>Prize|||||500|500|
|Lord NuBietd scholarship<br>in agercare|||||||
|Feilden nursing<br>scholarship|||||||
|Elizabeth Handfield<br>Jones travelling||scholarship|||||
|Girdlestone<br>Memorial<br>nursing<br>scholarship|||||||
|Course, confemnce<br>and travel grants|||||||
|Nu0reld Dept. ofOrthopaedic<br>Surgery research assistant|||||31,160|30,850|
|Grant forjournals and pmfessional|publications||||3,000||
|Joseph Trusts prize|||||||
|Unpaid prizes relating to earlier years||||||(5,300)|
|Grants and Awards from ttnrustricted|||Funds||132,760|110575|
|Total Grants and Awards for the|year||||||
|Unrestricted<br>fund||||Note 9|142,875|119,896|
|Endowment<br>funds - Expendable||||||1,000|
|Permanent|||||||
|Restricted funds|||||1,000||
||||||143,875|120896|





## 

## 

## 

||||||2022||ZOZ1|
|---|---|---|---|---|---|---|---|
||||||6||6|
|Tnlstccs Incctlngs||||||||
|Salary ofsecretary|||||8,140||7.665|
|Audit/Independent|examination||fee||1,425||1.380|
|Oftice expenses|||||550||276|
||||||~10115||9,321|
|12.Related Party|Transactions|||||||
|An objective ofthe|Trust is|to provide financial support toThe Nuffield||Department|ofOrthopaedic|Surgery at The||
|University ofOxford. Two||ofthe trustees, Professor Ai Carr and Professor IRees|||are employees ofThe University of|||
|Oxford.||||||||
|13.StaffCosts||||||||
||||||2022||2021|
|Salaries|||||8,140||7,665|
|National<br>insurance|costs|||||||
||||||8,140||7,665|
|The Trust hss one|pattkme|employee.||||||



|14.Ana|lysis ofAssets and L|iabilities||||||
|---|---|---|---|---|---|---|---|
|||||Kndswnwnt||||
|||Unnntrieted||Kspeudsbte|Penusneut||Tstst|
|||Funds|Funds|Funds|Funds|2022|2021|
|||6|6|6|E|6|6|
|Investments||5,041,345|52,991|82,086|46,680|5,223,102|5,021,437|
|Current|assets|130,111|22,282|14,582|5,787|172,762|239,731|
|Current|liabiTities|(69,205)||||(69305)|(61,202)|
|||5,102.251|75,273|96,668|52,467|5,326,659|5.199,966|





## 

## 

||||Unrestricted|Funds||Restricted|Endowment|Total|
|---|---|---|---|---|---|---|---|---|
||||Capital||Acclncome|Funds|Funds|2021|
||||f,||I||||
|Income and Endowments||from|||||||
|Stocks and shares|||||135,619|1,913|3,137|140.669|
|Deposit|interest||||220|3|5|228|
|Donations|||||5|0|0|5|
|Total Income|and Endowments||||135,844|1,916|3,142|140,902|
|Expenditure|on||||||||
|Charitable|activities||||(119,896)|0|(1,000)|(120,896)|
|Generating|funds||||||||
|Investment|management||(15,308)|||||(15,308)|
|Net gains/(losses)<br>on investments|||1,146,703|||16,176|26,524|1,189,403|
|Net Income/(expenditure)|||1,131,395||15,948|18,092|28,666|1,194,101|
|Other gains/losses|||||||||
|Net Movement|in Funds||1 131395||15,948|18092|28 666|1 194 101|